US Patent 8802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
Patent 8802110 was granted and assigned to Massachusetts Institute of Technology on August, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jul, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 26 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Aarthi Chandrasekaran0
Karthik Viswanathan0
Rahul Raman0
Ram Sasisekharan0
Xiaoying Koh0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines US Patent 8802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
Infobox
Patent Number
088021100
Patent Number
88021100
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
088021100
Date of Patent
August 12, 2014
0Patent Application Number
132393760
Date Filed
September 21, 2011
0Official Website
Patent Primary Examiner
Edits on 19 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08802110
Date of patent
August 12, 2014
Patent application number
13239376
Date Filed
September 21, 2011
Patent primary examiner
Find more entities like US Patent 8802110 Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
